Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Lung Neoplasms: HELP
Celine M. Mascaux
Based on 31 articles published since 2008
||||
Expertise Level
The expertise of Celine M. Mascaux ranks in the
  • Top 0.45%
  • ... of 233,087 published authors worldwide on Lung Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 31 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Mascaux, Céline   ·   Mascaux, C   ·   Mascaux, Celine M   ·   Mascaux, Celine
Work Locations
Details
Most likely:    Universite d'Aix-Marseille      
2018
  • Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France. · Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille Cancer Research Centre), Inserm UMR1068, CNRS UMR7258 and Aix-Marseille University UM105, Marseille, France. · Aix Marseille University, Assistance Publique des Hôpitaux de Marseille, Dept of Haematology and Paediatric Oncology, Marseille, France. · Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France · Pubmed 29540495
  • Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France. · Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France; Inserm UMR1068, CNRS UMR7258, UM105, université d'Aix-Marseille, predictive oncology laboratory, centre de recherche en cancérologie de Marseille, 13009 Marseille, France. · Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France; Inserm UMR1068, CNRS UMR7258, UM105, université d'Aix-Marseille, predictive oncology laboratory, centre de recherche en cancérologie de Marseille, 13009 Marseille, France. Electronic address: · Pubmed 30318433
  • Laboratory of Molecular Biology, Research Institute for Health Sciences and Technology, Université de Mons, Mons, Belgium. · Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Cellular and Molecular Epigenetics, Université de Liège-GIGA, Liège, Belgium. · Biostatistics Department, University of Toronto, Toronto, Canada. · Université Libre de Bruxelles (ULB), Bruxelles, Belgium. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Laboratory of Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Muldisciplinary Oncology and Therapeutic Innovations, Assistance Publique des Hôpitaux de Marseille (AP-HM), Aix-Marseille University, Chemin des Bourrely, 13195, Marseille, Cedex 20, France. · Centre de Recherche en Cancérologie de Marseille (CRCM, Cancer Research Center of Marseille), Inserm UMR1068, CNRS UMR7258 and Aix-Marseille University UM105, Marseille, France. · Pubmed 29661164
  • SMARTc Unit, Inserm S_911 CRO2, Aix-Marseille University, Marseille, France. · Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique Hôpitaux de Marseille, Marseille, France. · MONC Team, Inria Bordeaux Sud-Ouest, Talence, France. · Institut de Mathématiques de Bordeaux, UMR 5251, University of Bordeaux and CNRS, Talence, France. · Pubmed 29218795
2017
  • Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France · Aix Marseille University, Inserm U911 CRO2, Marseille, France. · Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France. · Pubmed 29141962
  • Aix Marseille University, APHM, Marseille Early Phases Cancer Trials Center CLIP, Marseille, France. · Aix Marseille University, SMARTc Unit, INSERM U911, Marseille, France. · Aix Marseille University, APHM, Department of Pharmacology, Marseille, France. · Aix Marseille University, APHM, Department of Pediatric Hematology and Oncology, Marseille, France. · Pubmed 28525370
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada; Division of Respirology and Thoracic Surgery, Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 Chemin Ste-Foy, Québec, QC, G1V 4G5, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. · Canadian Cancer Trials Group, Queen's University, 10 Stuard Street, Kingston, ON, K7L 3N6, Canada. Electronic address: · Aix-Marseille University, Public Assistance, Marseille Hospitals, 80 Rue Brochier, 13005 Marseille, France. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Aix-Marseille University, Public Assistance, Marseille Hospitals, 80 Rue Brochier, 13005 Marseille, France. Electronic address: · Division of Medical Oncology and Hematology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, Montreal, QC, H4J 1C5, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. Electronic address: · Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28838393
2016
  • Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Department of Neurosurgery, Aix-Marseille University, Marseille 13005, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. L' · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. L' · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Statistics Department, Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Pubmed 27999344
Probable:    INSERM France      
2018
  • Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France. · Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille Cancer Research Centre), Inserm UMR1068, CNRS UMR7258 and Aix-Marseille University UM105, Marseille, France. · Aix Marseille University, Assistance Publique des Hôpitaux de Marseille, Dept of Haematology and Paediatric Oncology, Marseille, France. · Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France · Pubmed 29540495
  • Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France. · Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France; Inserm UMR1068, CNRS UMR7258, UM105, université d'Aix-Marseille, predictive oncology laboratory, centre de recherche en cancérologie de Marseille, 13009 Marseille, France. · Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France; Inserm UMR1068, CNRS UMR7258, UM105, université d'Aix-Marseille, predictive oncology laboratory, centre de recherche en cancérologie de Marseille, 13009 Marseille, France. Electronic address: · Pubmed 30318433
  • Laboratory of Molecular Biology, Research Institute for Health Sciences and Technology, Université de Mons, Mons, Belgium. · Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Cellular and Molecular Epigenetics, Université de Liège-GIGA, Liège, Belgium. · Biostatistics Department, University of Toronto, Toronto, Canada. · Université Libre de Bruxelles (ULB), Bruxelles, Belgium. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Laboratory of Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Muldisciplinary Oncology and Therapeutic Innovations, Assistance Publique des Hôpitaux de Marseille (AP-HM), Aix-Marseille University, Chemin des Bourrely, 13195, Marseille, Cedex 20, France. · Centre de Recherche en Cancérologie de Marseille (CRCM, Cancer Research Center of Marseille), Inserm UMR1068, CNRS UMR7258 and Aix-Marseille University UM105, Marseille, France. · Pubmed 29661164
  • SMARTc Unit, Inserm S_911 CRO2, Aix-Marseille University, Marseille, France. · Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique Hôpitaux de Marseille, Marseille, France. · MONC Team, Inria Bordeaux Sud-Ouest, Talence, France. · Institut de Mathématiques de Bordeaux, UMR 5251, University of Bordeaux and CNRS, Talence, France. · Pubmed 29218795
2017
  • Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France · Aix Marseille University, Inserm U911 CRO2, Marseille, France. · Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France. · Pubmed 29141962
2016
  • Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Department of Neurosurgery, Aix-Marseille University, Marseille 13005, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. L' · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. L' · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Statistics Department, Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Pubmed 27999344
Probable:    Miscellaneous institutions in Marseille      
2018
  • SMARTc Unit, Inserm S_911 CRO2, Aix-Marseille University, Marseille, France. · Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique Hôpitaux de Marseille, Marseille, France. · MONC Team, Inria Bordeaux Sud-Ouest, Talence, France. · Institut de Mathématiques de Bordeaux, UMR 5251, University of Bordeaux and CNRS, Talence, France. · Pubmed 29218795
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 31 total) written by Celine M. Mascaux about Lung Neoplasms:

  • Drug repurposing in malignant pleural mesothelioma: a breath of fresh air? 2018
  • [Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report]. 2018
  • Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC). 2018
  • Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non-Small Cell Lung Carcinoma. 2018
  • Personalised medicine for nonsmall cell lung cancer. 2017
  • Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients. 2017
  • Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC). 2017
  • Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer. 2017
  • EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer. 2016
  • Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model. 2016
Show List of Full Article Records
Google Searches

Learn more about Celine M. Mascaux using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite d'Aix-Marseille
INSERM France
Miscellaneous institutions in Marseille
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite d'Aix-Marseille
2018
  • Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France. · Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille Cancer Research Centre), Inserm UMR1068, CNRS UMR7258 and Aix-Marseille University UM105, Marseille, France. · Aix Marseille University, Assistance Publique des Hôpitaux de Marseille, Dept of Haematology and Paediatric Oncology, Marseille, France. · Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France · Pubmed 29540495
  • Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France. · Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France; Inserm UMR1068, CNRS UMR7258, UM105, université d'Aix-Marseille, predictive oncology laboratory, centre de recherche en cancérologie de Marseille, 13009 Marseille, France. · Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France; Inserm UMR1068, CNRS UMR7258, UM105, université d'Aix-Marseille, predictive oncology laboratory, centre de recherche en cancérologie de Marseille, 13009 Marseille, France. Electronic address: · Pubmed 30318433
  • Laboratory of Molecular Biology, Research Institute for Health Sciences and Technology, Université de Mons, Mons, Belgium. · Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Cellular and Molecular Epigenetics, Université de Liège-GIGA, Liège, Belgium. · Biostatistics Department, University of Toronto, Toronto, Canada. · Université Libre de Bruxelles (ULB), Bruxelles, Belgium. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Laboratory of Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Muldisciplinary Oncology and Therapeutic Innovations, Assistance Publique des Hôpitaux de Marseille (AP-HM), Aix-Marseille University, Chemin des Bourrely, 13195, Marseille, Cedex 20, France. · Centre de Recherche en Cancérologie de Marseille (CRCM, Cancer Research Center of Marseille), Inserm UMR1068, CNRS UMR7258 and Aix-Marseille University UM105, Marseille, France. · Pubmed 29661164
  • SMARTc Unit, Inserm S_911 CRO2, Aix-Marseille University, Marseille, France. · Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique Hôpitaux de Marseille, Marseille, France. · MONC Team, Inria Bordeaux Sud-Ouest, Talence, France. · Institut de Mathématiques de Bordeaux, UMR 5251, University of Bordeaux and CNRS, Talence, France. · Pubmed 29218795
2017
  • Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France · Aix Marseille University, Inserm U911 CRO2, Marseille, France. · Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France. · Pubmed 29141962
  • Aix Marseille University, APHM, Marseille Early Phases Cancer Trials Center CLIP, Marseille, France. · Aix Marseille University, SMARTc Unit, INSERM U911, Marseille, France. · Aix Marseille University, APHM, Department of Pharmacology, Marseille, France. · Aix Marseille University, APHM, Department of Pediatric Hematology and Oncology, Marseille, France. · Pubmed 28525370
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada; Division of Respirology and Thoracic Surgery, Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 Chemin Ste-Foy, Québec, QC, G1V 4G5, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. · Canadian Cancer Trials Group, Queen's University, 10 Stuard Street, Kingston, ON, K7L 3N6, Canada. Electronic address: · Aix-Marseille University, Public Assistance, Marseille Hospitals, 80 Rue Brochier, 13005 Marseille, France. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Aix-Marseille University, Public Assistance, Marseille Hospitals, 80 Rue Brochier, 13005 Marseille, France. Electronic address: · Division of Medical Oncology and Hematology, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, Montreal, QC, H4J 1C5, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. Electronic address: · Department of Pathology, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada. Electronic address: · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28838393
2016
  • Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Department of Neurosurgery, Aix-Marseille University, Marseille 13005, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. L' · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. L' · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Statistics Department, Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Pubmed 27999344
INSERM France
2018
  • Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France. · Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille Cancer Research Centre), Inserm UMR1068, CNRS UMR7258 and Aix-Marseille University UM105, Marseille, France. · Aix Marseille University, Assistance Publique des Hôpitaux de Marseille, Dept of Haematology and Paediatric Oncology, Marseille, France. · Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France · Pubmed 29540495
  • Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France. · Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France; Inserm UMR1068, CNRS UMR7258, UM105, université d'Aix-Marseille, predictive oncology laboratory, centre de recherche en cancérologie de Marseille, 13009 Marseille, France. · Université d'Aix-Marseille, Assistance publique Hôpitaux de Marseille, centre essais précoces en cancérologie de Marseille CLIP2, hôpital La Timone, boulevard Saint-Pierre, 13005 Marseille, France; Inserm UMR1068, CNRS UMR7258, UM105, université d'Aix-Marseille, predictive oncology laboratory, centre de recherche en cancérologie de Marseille, 13009 Marseille, France. Electronic address: · Pubmed 30318433
  • Laboratory of Molecular Biology, Research Institute for Health Sciences and Technology, Université de Mons, Mons, Belgium. · Princess Margaret Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Cellular and Molecular Epigenetics, Université de Liège-GIGA, Liège, Belgium. · Biostatistics Department, University of Toronto, Toronto, Canada. · Université Libre de Bruxelles (ULB), Bruxelles, Belgium. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. · Laboratory of Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Muldisciplinary Oncology and Therapeutic Innovations, Assistance Publique des Hôpitaux de Marseille (AP-HM), Aix-Marseille University, Chemin des Bourrely, 13195, Marseille, Cedex 20, France. · Centre de Recherche en Cancérologie de Marseille (CRCM, Cancer Research Center of Marseille), Inserm UMR1068, CNRS UMR7258 and Aix-Marseille University UM105, Marseille, France. · Pubmed 29661164
  • SMARTc Unit, Inserm S_911 CRO2, Aix-Marseille University, Marseille, France. · Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique Hôpitaux de Marseille, Marseille, France. · MONC Team, Inria Bordeaux Sud-Ouest, Talence, France. · Institut de Mathématiques de Bordeaux, UMR 5251, University of Bordeaux and CNRS, Talence, France. · Pubmed 29218795
2017
  • Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France · Aix Marseille University, Inserm U911 CRO2, Marseille, France. · Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology and Therapeutic Innovations Dept, Marseille, France. · Pubmed 29141962
2016
  • Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Department of Neurosurgery, Aix-Marseille University, Marseille 13005, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. L' · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. L' · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Statistics Department, Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Transfer Oncology Laboratory, Aix Marseille University, Marseille 13015, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Assistance Publique Hôpitaux de Marseille, Multidisciplinary Oncology & Therapeutic Innovations department. Aix Marseille University, Marseille 13015, France. · Inserm U911 CRO2 (Centre de Recherche en Oncologie biologique et Onco-pharmacologie), Aix Marseille University, Marseille 13005, France. · Pubmed 27999344
Miscellaneous institutions in Marseille
2018
  • SMARTc Unit, Inserm S_911 CRO2, Aix-Marseille University, Marseille, France. · Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique Hôpitaux de Marseille, Marseille, France. · MONC Team, Inria Bordeaux Sud-Ouest, Talence, France. · Institut de Mathématiques de Bordeaux, UMR 5251, University of Bordeaux and CNRS, Talence, France. · Pubmed 29218795
University Health Network of Toronto
2017
  • Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada. · Laboratory Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada. · Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada. · Pubmed 28363487
2016
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, Roche Diagnostics GmbH, Mannheim, Germany. · Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 26926157
2015
  • Erin L. Stewart, Celine Mascaux, Nhu-An Pham, Shingo Sakashita, Jenna Sykes, Lucia Kim, Naoki Yanagawa, Ghassan Allo, Kota Ishizawa, Dennis Wang, Chang-Qi Zhu, Ming Li, Christine Ng, Ni Liu, Melania Pintilie, Petra Martin, Tom John, Igor Jurisica, Natasha B. Leighl, Benjamin G. Neel, Thomas K. Waddell, Frances A. Shepherd, Geoffrey Liu, Ming-Sound Tsao, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada · Lucia Kim, Inha University College of Medicine, Incheon, South Korea · and Tom John, Austin Hospital, Heidelberg, Australia. · Pubmed 26124487
2013
  • Princess Margaret Cancer Centre, University of Health Network, University of Toronto, Toronto, Ontario, Canada. · Pubmed 23931022
University of Toronto
2016
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. · Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, Roche Diagnostics GmbH, Mannheim, Germany. · Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 26926157
2015
  • Erin L. Stewart, Celine Mascaux, Nhu-An Pham, Shingo Sakashita, Jenna Sykes, Lucia Kim, Naoki Yanagawa, Ghassan Allo, Kota Ishizawa, Dennis Wang, Chang-Qi Zhu, Ming Li, Christine Ng, Ni Liu, Melania Pintilie, Petra Martin, Tom John, Igor Jurisica, Natasha B. Leighl, Benjamin G. Neel, Thomas K. Waddell, Frances A. Shepherd, Geoffrey Liu, Ming-Sound Tsao, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada · Lucia Kim, Inha University College of Medicine, Incheon, South Korea · and Tom John, Austin Hospital, Heidelberg, Australia. · Pubmed 26124487
2013
  • Princess Margaret Cancer Centre, University of Health Network, University of Toronto, Toronto, Ontario, Canada. · Pubmed 23931022
University of Colorado system
2013
  • Department of Medicine, Division of Medical Oncology, Colorado School of Public Health, Aurora, 80045, USA. · Pubmed 23268837
2011
  • Divisions of Medical Oncology and Pathology, University of Colorado Denver, Aurora, Colorado, USA. · Pubmed 21994417
2010
  • University of Colorado Denver, Anschutz Medical Campus, 12801 East 17th Avenue, Aurora, CO 80045, USA. · Pubmed 20843203
2013
  • Department of Medicine/Medical Oncology, University of Colorado Cancer Center, UC Denver, 12801 E 17th Ave, Mail Stop 8177, Aurora, CO 80045, USA. · Pubmed 23619944
2010
  • Division of Medical Oncology, University of Colorado Denver, Aurora, Colorado 80045, USA. · Pubmed 20697298
Colorado School of Public Health
2013
  • Department of Medicine, Division of Medical Oncology, Colorado School of Public Health, Aurora, 80045, USA. · Pubmed 23268837
Jules Bordet Institute
2009
  • Laboratoire d'Oncologie Thoracique, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles. · Pubmed 20666154
  • Institut Jules Bordet, Rue Héger-Bordet 1, B-1000 Brussels, Belgium. · Pubmed 19010987
2008
  • Département de Soins Intensifs et d'Oncologie Thoracique, Institut Jules-Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, 1 Rue Héger-Bordet, Brussels, Belgium. · Pubmed 18971824
  • Dept of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, B-1000 Brussels, Belgium. · Pubmed 18480108
2013
  • Department of Oncological Intensive Care and Emergencies & Thoracic Oncology, Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: · Pubmed 24007627
2011
  • Département d'Oncologie Thoracique et Soins Intensifs et Data Centre,Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21273611
2010
  • Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 20234323
2008
  • Department of Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bruxelles, Belgium. · Pubmed 18166834
  • Department of Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, ULB (Université Libre de Bruxelles), Bruxelles, Belgium. · Pubmed 18355939
Universite Libre de Bruxelles
2008
  • Dept of Intensive Care and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, B-1000 Brussels, Belgium. · Pubmed 18480108
2013
  • Department of Oncological Intensive Care and Emergencies & Thoracic Oncology, Université Libre de Bruxelles (ULB), Brussels, Belgium. Electronic address: · Pubmed 24007627
2011
  • Département d'Oncologie Thoracique et Soins Intensifs et Data Centre,Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 21273611
2010
  • Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 20234323
2008
  • Department of Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Bruxelles, Belgium. · Pubmed 18166834
  • Department of Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, ULB (Université Libre de Bruxelles), Bruxelles, Belgium. · Pubmed 18355939
5 Other Locations Show
Yearly article counts 044211612424
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.